<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	>
 <channel>
  <title>N</title>
  <link>http://www.investorsparadise.com/forum/</link>
  <generator>http://www.eblah.com</generator>
  <description></description>
  <language>en</language>
  <item>
   <title>NEM</title>
   <link>http://www.investorsparadise.com/forum/m-1183734953/</link>
   <comments>http://www.investorsparadise.com/forum/m-1183734953/#num1</comments>
   <description><![CDATA[Newmont Eliminates Gold Hedges, Creating the World's Largest Unhedged Gold Company, and Announces Strategic Initiatives<br /><br />DENVER, Jul 5, 2007 (Canada NewsWire via COMTEX) -- Newmont Mining Corporation (NYSE: NEM) today announced the elimination of its entire 1.85 million ounce gold hedge position, establishing the Company as the world's largest unhedged gold producer. Newmont also announced plans to monetize components of its royalty and equity portfolio in the next twelve months, resulting in the discontinuation of the Company's Merchant Banking Segment as a separate business unit.<br /><br />Commenting on the Company's strategic initiatives, newly appointed Chief Executive Officer, Richard O'Brien, said, "With the elimination of our gold hedge book, we have renewed our commitment to maximizing gold price leverage for our shareholders. In addition, we are focused on delivering improvements in our operating performance and cost structure going forward. We intend to realize the value from a significant portion of our non-core, Merchant Banking portfolio and use the proceeds to fund the development and growth of our core gold business."<br /><br />During June 2007, the Company spent $578 million to eliminate its entire 1.85 million ounce price-capped forward sales contracts. The Company will report a pre-tax loss of approximately $531 million on the early settlement of these contracts, after a $47 million reversal of previously recognized deferred revenue.<br /><br />In addition, as a result of the Company's decision to discontinue its Merchant Banking Segment and monetize components of its equity and royalty portfolio, the carrying value of the Merchant Banking Segment goodwill was impaired as of June 30, 2007. Consequently, the Company expects to incur a non-cash impairment charge of approximately $1.7 billion, to be recorded as part of discontinued operations, in the second quarter of 2007. The Company has engaged financial and legal advisors to evaluate alternatives to maximize the realized value of the discontinued Merchant Banking portfolio. Potential alternatives include, among others, a public offering and/or private sale transactions.<br /><br />Commenting on the Company's path forward, Mr. O'Brien said, "These transactions form the foundation of a renewed focus on our core gold business. Looking forward, we intend to maximize gold price leverage for our shareholders, establish a sustainable and reliable production base at competitive operating and capital costs, maintain our financial strength and flexibility, and capitalize on our exploration portfolio and land position." ]]></description>
   <pubDate>Fri, 6 Jul 2007 11:15:53</pubDate>
   <dc:creator>popeye</dc:creator>
  </item>
  <item>
   <title>NVS - Novartis Gets EU OK for New Flu Vaccine</title>
   <link>http://www.investorsparadise.com/forum/m-1181745985/</link>
   <comments>http://www.investorsparadise.com/forum/m-1181745985/#num1</comments>
   <description><![CDATA[Novartis Gets EU OK for New Flu Vaccine<br />Wednesday June 13, 8:43 am ET&nbsp;&nbsp;<br />Novartis Receives European Union Approval for Its New Flu Vaccine Optaflu <br /><br /><br />BASEL, Switzerland (AP) -- Novartis AG has received European Union approval for flu vaccine Optaflu, the Swiss drugmaker said Wednesday.<br />Iceland and Norway also have approved Optaflu for use in vaccination against seasonal influenza, Novartis said, adding that its use of proprietary cell culture technology could help in the event of a flu pandemic.<br /><br />Continued: <a href="http://biz.yahoo.com/ap/070613/novartis_flu_vaccine.html?.v=3">http://biz.yahoo.com/ap/070613/novartis_flu_vaccine.html?.v=3</a>]]></description>
   <pubDate>Wed, 13 Jun 2007 10:46:25</pubDate>
   <dc:creator>DeMerchant</dc:creator>
  </item>
  <item>
   <title>NYMX - NYMOX PHARM CORP</title>
   <link>http://www.investorsparadise.com/forum/m-1173814690/</link>
   <comments>http://www.investorsparadise.com/forum/m-1173814690/#num1</comments>
   <description><![CDATA[Is this still a hold for you guys?]]></description>
   <pubDate>Tue, 13 Mar 2007 15:38:10</pubDate>
   <dc:creator>ian993</dc:creator>
  </item>
  <item>
   <title>NXTM - Nxstage Medical, Inc.</title>
   <link>http://www.investorsparadise.com/forum/m-1172579260/</link>
   <comments>http://www.investorsparadise.com/forum/m-1172579260/#num1</comments>
   <description><![CDATA[Looking for this to head sideways and gain some accumulation]]></description>
   <pubDate>Tue, 27 Feb 2007 07:27:40</pubDate>
   <dc:creator>Market Speculator</dc:creator>
  </item>
  <item>
   <title>NSTC - NESS TECHNOLOGIES INC</title>
   <link>http://www.investorsparadise.com/forum/m-1171395726/</link>
   <comments>http://www.investorsparadise.com/forum/m-1171395726/#num1</comments>
   <description><![CDATA[This is one to keep on your watch list.<br /><br />It is holding its 200dma.&nbsp;&nbsp;Look for it to form a saucer or cup w/handle chart formation.&nbsp;&nbsp;This one will take a while but selling looks like its done.<br /><br />]]></description>
   <pubDate>Tue, 13 Feb 2007 14:42:06</pubDate>
   <dc:creator>Market Speculator</dc:creator>
  </item>
  <item>
   <title>NSIT - Insight Enterprises Inc.</title>
   <link>http://www.investorsparadise.com/forum/m-1159981897/</link>
   <comments>http://www.investorsparadise.com/forum/m-1159981897/#num1</comments>
   <description><![CDATA[NSIT&nbsp;&nbsp;This is not an exact break out spot but is is a play I think on a break and notice the crossing of the 200 and 50-day EMA<br /><br /><br /><br /><img class="imgcode" src="http://stockcharts.com/c-sc/sc?s=NSIT&amp;p=D&amp;st=2006-03-01&amp;i=p83767118021&amp;a=85552357&amp;r=2889" alt="" />]]></description>
   <pubDate>Wed, 4 Oct 2006 13:11:37</pubDate>
   <dc:creator>StockTiger</dc:creator>
  </item>
  <item>
   <title>NABI - Watch out</title>
   <link>http://www.investorsparadise.com/forum/m-1154022284/</link>
   <comments>http://www.investorsparadise.com/forum/m-1154022284/#num1</comments>
   <description><![CDATA[The problem with pharma companies that are heavily counting on one drug to work and get approved is that if said drug doesn’t work as well as hoped and get approved then you can take some major losses... nothing has reward without risk... but what i saw this one does look fairly promising... <br><br>This company's balance sheet is also very strong... it has almost a 3x<br><br>That being said they have been issueing quite a large amount of stock for quite some time...<br><br>Definatly not the wost company i have looked at but if this drug fails for soem reason it could spell some LARGE losses... but like I also said no risk it without its reward ]]></description>
   <pubDate>Thu, 27 Jul 2006 13:44:44</pubDate>
   <dc:creator>eugj</dc:creator>
  </item>
  <item>
   <title>NFS - Nationwide</title>
   <link>http://www.investorsparadise.com/forum/m-1152644848/</link>
   <comments>http://www.investorsparadise.com/forum/m-1152644848/#num1</comments>
   <description><![CDATA[Earnings Growth Seen Slowing For Insurers ... <a href="http://www.forbes.com/2006/07/11/metlife-prudential-0711markets07.html?partner=alerts">http://www.forbes.com/2006/07/11/metlife-prudential-0711markets07.html?partner=alerts</a>]]></description>
   <pubDate>Tue, 11 Jul 2006 15:07:28</pubDate>
   <dc:creator>DeMerchant</dc:creator>
  </item>
  <item>
   <title>NRMX - Neurochem</title>
   <link>http://www.investorsparadise.com/forum/m-1150887120/</link>
   <comments>http://www.investorsparadise.com/forum/m-1150887120/#num1</comments>
   <description><![CDATA[Neurochem's Fibrillex Application Warrants Caution, Says Analyst ... <a href="http://www.forbes.com/2006/06/20/neurochem-0620markets10.html?partner=alerts">http://www.forbes.com/2006/06/20/neurochem-0620markets10.html?partner=alerts</a>]]></description>
   <pubDate>Wed, 21 Jun 2006 06:52:00</pubDate>
   <dc:creator>DeMerchant</dc:creator>
  </item>
  <item>
   <title>NYT - New York Times</title>
   <link>http://www.investorsparadise.com/forum/m-1150714162/</link>
   <comments>http://www.investorsparadise.com/forum/m-1150714162/#num1</comments>
   <description><![CDATA[New York Times-Metro Papers Announce Ad Deal ... <a href="http://www.forbes.com/2006/06/16/new-york-times-0616markets19.html?partner=alerts">http://www.forbes.com/2006/06/16/new-york-times-0616markets19.html?partner=alerts</a>]]></description>
   <pubDate>Mon, 19 Jun 2006 06:49:22</pubDate>
   <dc:creator>DeMerchant</dc:creator>
  </item>
 </channel>
</rss>